Intranasal unadjuvanted PspA spikes lung-resident memory immunity after parenteral pneumococcal vaccination
Molecular Therapy · 2026
DOI: 10.1016/j.ymthe.2026.01.042 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026. Verfasst von Saugata Majumder und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA. Hauptthemen laut MEDLINE: Pneumococcal Vaccines, Immunologic Memory, Streptococcus pneumoniae, Lung. Die Arbeit nennt 66 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, National Institutes of Health.
Abstract (Originalsprache)
Intramuscular (IM) prime-boost vaccination with outer membrane vesicle (OMV)-delivered pneumococcal surface protein A (OMV-PspA) formulated with alum is safe but it compromises protection against respiratory Streptococcus pneumoniae (Spn) infections. To enhance pulmonary immunity, we employ a "prime-spike" strategy: IM OMV-PspA/alum prime-boost followed by an intranasal booster with adjuvant-free PspA. The immunization regimen demonstrates a favorable safety profile in mice and provided robust, nearly complete protection against Spn D39 (serotype 2) and A66.1 (serotype 3) strains during both primary infection and influenza-induced secondary infection. The induced PspA-specific antibodies exhibit potent opsonophagocytic killing of clinical isolates. Moreover, the strategy significantly increases lung-resident memory B cells, antibody-secreting cells (ASCs), tissue-resident memory T cells, and their respective interferon-γ-, tumor necrosis factor-α-, interleukin (IL)-17A-, and IL-4-producing cells. These findings strongly support the prime-spike approach as a promising strategy against both primary and secondary respiratory pneumococcal disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA.
- Department of Molecular and Cellular Physiology, Albany Medical College, Albany, NY 12208, USA.
- Department of Immunology and Microbial Disease, Albany Medical College, Albany, NY 12208, USA. Electronic address: sunw@amc.edu.
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- National Institutes of Health
Zitieren
APA
Majumder, S., Das, S., Saqib, M., Duncan, K., Bissell, G., & Sun, W. (2026). Intranasal unadjuvanted PspA spikes lung-resident memory immunity after parenteral pneumococcal vaccination. Molecular Therapy. https://doi.org/10.1016/j.ymthe.2026.01.042
Vancouver
Majumder S, Das S, Saqib M, Duncan K, Bissell G, Sun W. Intranasal unadjuvanted PspA spikes lung-resident memory immunity after parenteral pneumococcal vaccination. Molecular Therapy. 2026. doi:10.1016/j.ymthe.2026.01.042
BibTeX
@article{Majumder2026,
author = {Majumder, Saugata and Das, Shreya and Saqib, Mohd and Duncan, Kayley and Bissell, Grace and Sun, Wei},
title = {Intranasal unadjuvanted PspA spikes lung-resident memory immunity after parenteral pneumococcal vaccination},
journal = {Molecular Therapy},
year = {2026},
doi = {10.1016/j.ymthe.2026.01.042}
}
EUVIMED